Cornea · 2016 · 43 citations · 24 references
Rituximab achieved a high rate of disease control in PUK patients with GPA and is the preferred agent in halting disease progression.
24
Wegener Granulomatosis: An Analysis of 158 Patients
Gary S. Hoffman, Gail S. Kerr, Randi Y. Leavitt et al. · Annals of Internal Medicine · 1992 · 2.9K citations
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
John H. Stone, Peter A. Merkel, Robert Spiera et al. · New England Journal of Medicine · 2010 · 2.7K citations · Full text
Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
Christian Pagnoux, Alexandre Karras, C. Khouatra et al. · New England Journal of Medicine · 2014 · 1.1K citations · Full text
Ocular Complications of Wegener's Granulomatosis
Cynthia L. Bullen, Thomas J. Liesegang, Thomas J. McDonald et al. · Ophthalmology · 1983 · 384 citations